Literature DB >> 18435757

Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.

Harald Kolmar1.   

Abstract

Cystine-knot miniproteins are members of a large family of small proteins that are defined by a common structural scaffold which is stabilized by three intramolecular disulfide bonds. Cystine-knot miniproteins display a broad spectrum of therapeutically useful natural biological activities and several family members are marketed as therapeutics or are in clinical development. Because of their extraordinary intrinsic chemical and proteolytic stability they provide promising scaffolds for the introduction of therapeutically relevant functionalities. Several successful engineering efforts have been reported to generate miniproteins with novel activities by rational design via functional loop grafting or by directed evolution via screening of scaffold-constrained random libraries. Owing to their small size they are amenable to recombinant as well as to chemical routes of synthesis, which opens up new avenues in optimizing biological activity, specificity and bioavailability by site-specific modification, introduction of non-natural amino acids or chemical conjugation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435757     DOI: 10.1111/j.1742-4658.2008.06440.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  31 in total

1.  Evolving the use of peptides as components of biomaterials.

Authors:  Joel H Collier; Tatiana Segura
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

Review 2.  Mechanisms of macromolecular protease inhibitors.

Authors:  Christopher J Farady; Charles S Craik
Journal:  Chembiochem       Date:  2010-11-22       Impact factor: 3.164

Review 3.  Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.

Authors:  Brad R Green; Grzegorz Bulaj; Raymond S Norton
Journal:  Future Med Chem       Date:  2014-10       Impact factor: 3.808

4.  Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation.

Authors:  Nick Cox; James R Kintzing; Mark Smith; Gerald A Grant; Jennifer R Cochran
Journal:  Angew Chem Int Ed Engl       Date:  2016-06-15       Impact factor: 15.336

5.  Isolation of monobodies that bind specifically to the SH3 domain of the Fyn tyrosine protein kinase.

Authors:  Renhua Huang; Pete Fang; Brian K Kay
Journal:  N Biotechnol       Date:  2011-12-06       Impact factor: 5.079

6.  Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.

Authors:  Laura Cascales; Sónia T Henriques; Markus C Kerr; Yen-Hua Huang; Matthew J Sweet; Norelle L Daly; David J Craik
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

7.  Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Authors:  Toni Hoffmann; Lukas Kurt Josef Stadler; Michael Busby; Qifeng Song; Anthony T Buxton; Simon D Wagner; Jason J Davis; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2010-02-23       Impact factor: 1.650

8.  Rapid sensitive analysis of cysteine rich peptide venom components.

Authors:  Beatrix M Ueberheide; David Fenyö; Paul F Alewood; Brian T Chait
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

9.  Complete mapping of a cystine knot and nested disulfides of recombinant human arylsulfatase A by multi-enzyme digestion and LC-MS analysis using CID and ETD.

Authors:  Wenqin Ni; Melanie Lin; Paul Salinas; Philip Savickas; Shiaw-Lin Wu; Barry L Karger
Journal:  J Am Soc Mass Spectrom       Date:  2012-12-04       Impact factor: 3.109

10.  Interrogating and predicting tolerated sequence diversity in protein folds: application to E. elaterium trypsin inhibitor-II cystine-knot miniprotein.

Authors:  Jennifer L Lahti; Adam P Silverman; Jennifer R Cochran
Journal:  PLoS Comput Biol       Date:  2009-09-04       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.